Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Yasheng Pharmaceutical
Suzhou, Jiangsu, China
- Ownership
- Private
- Employees
- ~350
- Development stage
- Other
01
Overview
Suzhou Yasheng Pharmaceutical has advanced several novel small molecule drugs targeting cancer and hematologic/immune diseases, including olverembatinib (HQP1351), which is in NDA/Phase 3 for TKI-resistant CML, and other compounds in Phase 2/Phase 1 for hematologic and solid tumors. The company’s candidates are recognized internationally with multiple FDA orphan drug and fast track designations, collaborations, and presentations at global oncology conferences.
- Therapeutic areas
- ImmunologyEndocrinologyInfectious DiseasesNeurologyHematologyOncology
- Modalities
- Small moleculeChemical drugProteolysis-targeting chimera therapy (PROTAC)Monoclonal antibody
- Industry
- Biotech
02
Partnerships
Innovent Biologics (Cinda)TakedaMerckAstraZenecaPfizerNational Cancer Institute (NCI)MD Anderson Cancer CenterMayo ClinicDana-Farber Cancer InstituteUniversity of Michigan
Beyond the preview
Go deeper on Suzhou Yasheng Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Suzhou Yasheng Pharmaceutical.